Sanghamitra Mylavarapu

Title: Sanghamitra Mylavarapu: Innovator in Supramolecular Combinatorial Therapeutics

Introduction

Sanghamitra Mylavarapu is a notable inventor based in Delhi, India. She has made significant contributions to the field of supramolecular combinatorial therapeutics. Her innovative work focuses on enhancing the efficacy of cancer treatments through advanced therapeutic compositions.

Latest Patents

Sanghamitra holds a patent for her work titled "Supramolecular Combinatorial Therapeutics." This patent relates to compositions that include hydrophobic taxane-lipid covalent conjugates. These conjugates create supramolecular assemblies within lipid bilayers, which provide extra stabilization. This stabilization results in increased intratumoral concentration and enhanced efficacy of the therapeutic agents. The patent also discusses the combination of taxane-lipid conjugates with platinum compounds, kinase inhibitors, and immunoregulators, each of which may be conjugated with a lipid.

Career Highlights

Throughout her career, Sanghamitra has worked with various organizations, including Invictus Oncology Pvt. Ltd. and Alyssum Therapeutics, Inc. Her experience in these companies has allowed her to develop and refine her innovative approaches to cancer therapeutics.

Collaborations

Sanghamitra has collaborated with notable colleagues, including Monideepa Roy and Samad Hossain. These collaborations have contributed to her research and development efforts in the field of supramolecular therapeutics.

Conclusion

Sanghamitra Mylavarapu is a pioneering inventor whose work in supramolecular combinatorial therapeutics is paving the way for more effective cancer treatments. Her contributions to the field are significant and continue to inspire further research and innovation.